TY - JOUR
T1 - Hyaluronic acid in the management of osteoarthritis
T2 - Injection therapies innovations
AU - Santilli, Valter
AU - Paoloni, Marco
AU - Mangone, Massimiliano
AU - Alviti, Federica
AU - Bernetti, Andrea
PY - 2016/5/1
Y1 - 2016/5/1
N2 - Osteoarthritis (OA) is a chronic degenerative joint disease characterized by pain and progressive functional limitation. Viscosupplementation with intra-articular (IA) hyaluronic acid (HA) could be a treatment option in OA, however recommendations made in different international guidelines for the non-surgical management of OA are not always concordant with regard to the role of IA injection therapies. Results from a recent Italian Consensus Conference underline how IA-HA to treat OA represents a widely used therapy in Italy. Specifically high molecular weight HA, crosslinked HA, and mobile reticulum HA are considered very useful to treat the OA joints from a great number of expert in Italy. These kinds of HA could reduce the NSAIDs intake, furthermore high-molecular weight and mobile reticulum HA are considered to be able to delay or avoid a joint prosthetic implant. This mini review highlights the results obtained from the Italian Consensus Conference "Appropriateness of clinical and organizational criteria for intra-articular injection therapies in osteoarthritis" and give further indication about innovation in IA-HA therapies.
AB - Osteoarthritis (OA) is a chronic degenerative joint disease characterized by pain and progressive functional limitation. Viscosupplementation with intra-articular (IA) hyaluronic acid (HA) could be a treatment option in OA, however recommendations made in different international guidelines for the non-surgical management of OA are not always concordant with regard to the role of IA injection therapies. Results from a recent Italian Consensus Conference underline how IA-HA to treat OA represents a widely used therapy in Italy. Specifically high molecular weight HA, crosslinked HA, and mobile reticulum HA are considered very useful to treat the OA joints from a great number of expert in Italy. These kinds of HA could reduce the NSAIDs intake, furthermore high-molecular weight and mobile reticulum HA are considered to be able to delay or avoid a joint prosthetic implant. This mini review highlights the results obtained from the Italian Consensus Conference "Appropriateness of clinical and organizational criteria for intra-articular injection therapies in osteoarthritis" and give further indication about innovation in IA-HA therapies.
KW - Hyaluronic acid
KW - Injections
KW - Osteoarthritis
UR - http://www.scopus.com/inward/record.url?scp=84990173898&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84990173898&partnerID=8YFLogxK
U2 - 10.11138/ccmbm/2016.13.2.131
DO - 10.11138/ccmbm/2016.13.2.131
M3 - Article
AN - SCOPUS:84990173898
VL - 13
SP - 131
EP - 134
JO - Clinical Cases in Mineral and Bone Metabolism
JF - Clinical Cases in Mineral and Bone Metabolism
SN - 1724-8914
IS - 2
ER -